168 research outputs found

    Comparison Of Structure And Properties Of Femtosecond And Nanosecond Laser-Structured Silicon

    Get PDF
    We compare the optical properties,chemical composition, and crystallinity of siliconmicrostructures formed in the presence of SF6 by femtosecond laserirradiation and by nanosecond laser irradiation. In spite of very different morphology and crystallinity, the optical properties and chemical composition of the two types of microstructures are very similar. The structures formed with femtosecond (fs) pulses are covered with a disordered nanocrystalline surface layer less than 1 ÎŒm thick, while those formed with nanosecond (ns) pulses have very little disorder. Both ns-laser-formed and fs-laser-formed structures absorb near-infrared (1.1–2.5 Όm) radiation strongly and have roughly 0.5% sulfur impurities

    Species diversity promotes facilitation under stressful conditions

    Get PDF
    Climate change is expected to lead to a drier world, with more frequent and severe droughts, constituting a growing threat to biodiversity, especially in drylands. Positive plant−plant interactions, such as nurse plants facilitating beneficiary communities in their understorey, could mitigate such climate‐induced stress. However, testing the real‐world relevance of nurse facilitation under drought requires accounting for interactions within the diverse beneficiary communities, which may reduce, or amplify the buffering effect of a nurse. Here, we investigated when and how the interactions among nurse plants and beneficiary community members buffered drought effects in a Mediterranean semiarid abandoned cropland. We transplanted sapling beneficiary communities of either one or three species either under a nurse or in open microsites for different soil moisture levels through watering. Net facilitative effects on survival and biomass were only observed when beneficiary communities were species‐diverse and under drought (without watering), meaning that under these conditions, facilitation provided by the nurse had larger positive effects than the negative effects stemming from competition with the nurse and among beneficiary species. Nurses appear to be generating these increases in survival and biomass in drought conditions via two mechanisms commonly associated with watering in open sites: they generate complementarity among the beneficiaries and shift traits to lower stress profiles. Contrasting with watering, which was found to enhance competitive hierarchy, our study shows that nurses appear to alter species dominance, favouring the less competitive species. Our results highlight three mechanisms (complementarity, competitive dominance, and trait plasticity) by which nurse species could mitigate the loss of biodiversity and biomass production due to water stress. Maintaining and supporting nurse species is thus a potentially pivotal approach in the face of projected increase in drought conditions for many drylands across the world

    Mise Ă  jour des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers du sein en France

    Get PDF
    En Europe, les patientes atteintes d’un cancer du sein invasif susceptibles de recevoir un traitement ciblĂ© anti-HER2 sont actuellement sĂ©lectionnĂ©es sur la base d’un test immunohistochimique (IHC). Les techniques d’hybridation in situ (HIS) doivent ĂȘtre utilisĂ©es pour l’évaluation des cas IHC ambigus (2+) et pour l’étalonnage de la technique IHC. Les patientes Ă©ligibles au traitement ciblant HER2 prĂ©sentent un statut HER2 positif dĂ©fini par un test IHC 3+ ou un test 2+ amplifiĂ©. Une dĂ©tection correcte du statut HER2 est indispensable Ă  une utilisation optimale des thĂ©rapeutiques ciblĂ©es puisque leur efficacitĂ© est limitĂ©e aux patientes surexprimant HER2. Il est capital que l’évaluation du statut HER2 soit optimisĂ©e et fiable. Ces recommandations du groupe d’étude des facteurs pronostiques IHC dans le cancer du sein (GEFPICS) dĂ©taillent et commentent les diffĂ©rentes Ă©tapes des techniques IHC et HIS, les contrĂŽles utilisables et les rĂšgles gĂ©nĂ©rales de l’apprentissage de la lecture. Une fois acquis, ce savoir-faire doit ĂȘtre pĂ©rennisĂ© par l’observation de rĂšgles de bonnes pratiques techniques (utilisation rigoureuse de tĂ©moins internes et externes et participation rĂ©guliĂšre Ă  des programmes d’Assurance qualitĂ© [AQ])., Summary In Europe, patients who may benefit from an HER2 targeted drug are currently selected by immunohistochemistry (IHC). In situ hybridization (ISH) techniques should be used for complementary assessment of ambiguous 2+ IHC cases and for the calibration of the IHC technique. Eligibility to an HER2 target treatment is defined by an HER2 positive status being IHC test 3+ or 2+ amplified. Reliable detection of HER2 status is essential to the appropriate usage of HER2 targeted drugs because its specificity is limited to tumors overexpressing HER2. It is essential that the IHC evaluation of the HER2 status of a mammary carcinoma is optimized and reliable. This GEFPICS’ guidelines look over the different steps of the IHC technique, the controls and, the rules for interpretation. Once acquired, this knowledge must be perpetuated by the observation of rules of good technical practice (internal and external controls, quality assurance programs)

    Mise Ă  jour 2014 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers du sein en France

    Get PDF
    De nouvelles recommandations internationales pour l’évaluation du statut HER2 dans les cancers du sein, basĂ©es sur plus de dix ans d’expĂ©rience et sur les rĂ©sultats d’études cliniques et de concordance entre les diffĂ©rentes techniques de dĂ©tection, viennent tout juste de voir le jour. Le prĂ©sent article a pour objet de faire le point sur ces nouvelles recommandations, Ă  la lumiĂšre de la publication rĂ©cente du groupe de travail de l’American Society of Clinical Oncology (ASCO) et du CollĂšge des pathologistes amĂ©ricains (CAP), adaptĂ©es Ă  la pratique de la pathologie en France et revues par le groupe GEFPICS. À l’ùre de la mĂ©decine personnalisĂ©e, la dĂ©termination du statut HER2 reste un Ă©lĂ©ment phare dans le panel des biomarqueurs thĂ©ranostiques des cancers du sein. Si l’interprĂ©tation du statut HER2 dans les cancers du sein est aisĂ©e dans la majoritĂ© des cas, un certain nombre de situations anatomocliniques est d’interprĂ©tation plus dĂ©licate, telles que la possibilitĂ© rare mais rĂ©elle de l’hĂ©tĂ©rogĂ©nĂ©itĂ© intra-tumorale du statut de HER2, les formes Ă  diffĂ©renciation micropapillaire ou la rĂ©-Ă©valuation du statut des biomarqueurs lors de la rechute mĂ©tastatique. Ces nouvelles recommandations abordent ces diffĂ©rentes questions, reprĂ©cisent les conditions prĂ©-analytiques optimales et les critĂšres d’interprĂ©tation (notamment des cas 2+), afin de rĂ©duire au maximum le risque de faux nĂ©gatifs. Plus que jamais, la mobilisation de la spĂ©cialitĂ© d’anatomo-cytopathologie autour de la qualitĂ© des tests thĂ©ranostiques tĂ©moigne de son implication dans la chaĂźne des soins en cancĂ©rologie., Summary International guidelines on HER2 determination in breast cancer have just been updated by the American Society of Clinical Oncology (ASCO) and College of American Pathologists (CAP), on the basis of more than ten-year practice, results of clinical trials and concordance studies. The GEFPICS group, composed of expert pathologists in breast cancer, herein presents these recommendations, adapted to the French routine practice. These guidelines highlight the possible diagnosis difficulties with regards to HER2 status determination, such as intra-tumor heterogeneity, special histological subtypes and biomarker re-evaluation during metastatic relapse. Pre-analytical issues and updated scoring criteria (especially for equivocal cases) are detailed, in order to decrease the occurrence of false negative cases. In the era of personalized medicine, pathologists are more than ever involved in the quality of oncotheranostic biomarker evaluation.

    SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration

    Get PDF
    The G4C2-repeat expansion in C9orf72 is the most common cause of frontotemporal dementia and of amyotrophic lateral sclerosis. The variability of age at onset and phenotypic presentations is a hallmark of C9orf72 disease. In this study, we aimed to identify modifying factors of disease onset in C9orf72 carriers using a family-based approach, in pairs of C9orf72 carrier relatives with concordant or discordant age at onset. Linkage and association analyses provided converging evidence for a locus on chromosome Xq27.3. The minor allele A of rs1009776 was associated with an earlier onset (P = 1 × 10-5). The association with onset of dementia was replicated in an independent cohort of unrelated C9orf72 patients (P = 0.009). The protective major allele delayed the onset of dementia from 5 to 13 years on average depending on the cohort considered. The same trend was observed in an independent cohort of C9orf72 patients with extreme deviation of the age at onset (P = 0.055). No association of rs1009776 was detected in GRN patients, suggesting that the effect of rs1009776 was restricted to the onset of dementia due to C9orf72. The minor allele A is associated with a higher SLITRK2 expression based on both expression quantitative trait loci (eQTL) databases and in-house expression studies performed on C9orf72 brain tissues. SLITRK2 encodes for a post-synaptic adhesion protein. We further show that synaptic vesicle glycoprotein 2 and synaptophysin, two synaptic vesicle proteins, were decreased in frontal cortex of C9orf72 patients carrying the minor allele. Upregulation of SLITRK2 might be associated with synaptic dysfunctions and drives adverse effects in C9orf72 patients that could be modulated in those carrying the protective allele. How the modulation of SLITRK2 expression affects synaptic functions and influences the disease onset of dementia in C9orf72 carriers will require further investigations. In summary, this study describes an original approach to detect modifier genes in rare diseases and reinforces rising links between C9orf72 and synaptic dysfunctions that might directly influence the occurrence of first symptoms
    • 

    corecore